Brought to you by 
Series A brings in $21mm for Alvine Pharmaceuticals
14 Mar 2011
Executive Summary
Alvine Pharmaceuticals (therapeutics for celiac disease) raised $21mm through its Series A financing round led by Sofinnova Ventures with additional participation from Prospect Venture Partners, InterWest Partners, Cargill Ventures, and Flagship Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com